The global 3D medical imaging devices market is estimated to reach USD 20.31 billion by 2030, registering a CAGR of 8.04% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing prevalence of cardiovascular diseases, Alzheimer’s, cancer, and other chronic diseases. Moreover, the rise in healthcare expenditure across developed economies and rapid technological advancements are some of the other factors responsible for the market growth.
Furthermore, continuous advancements in imaging technology play an important role in driving market growth. Innovations in modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound have led to higher-resolution 3D imaging, allowing for more precise and detailed visualization of anatomical structures and pathological conditions. Healthcare providers are increasingly seeking state-of-the-art imaging equipment, which fuels the demand for 3D medical imaging devices.
Competition among medical device manufacturers and the introduction of new and innovative 3D imaging devices are driving market growth as companies strive to offer cutting-edge solutions. For instance, in August 2023, GigXR, Inc. launched an application, XR Library, which is driven by INTRAVISION XR, as part of its immersive learning platform. This innovative application provides a comprehensive collection of 3D medical visuals derived from CT and MRI scans. Similarly, in September 2022, GE Healthcare received FDA authorization for its AIR Recon, an advanced 3D and motion-insensitive imaging applications. This development promises to enhance the overall quality of MRI images while providing a more enhanced experience for patients. These factors are further contributing to market growth.
Request a free sample copy or view report summary: 3D Medical Imaging Devices Market Report
Based on device type, the hardware segment dominated the market in 2022 with a revenue share of over 67.52%. The hardware is essential for capturing the images and data required for 3D medical imaging. Without the hardware devices, 3D medical imaging would is not possible
In terms of applications, the oncology segment dominated the market in 2022 with a revenue share of more than 33%. The growth of the segment is attributed to the increasing prevalence of cancer globally
In terms of end-use, the hospitals segment dominated the market in 2022 with the largest revenue share of 48.35%. Hospitals offer a wide range of medical services, from routine check-ups to complex surgeries and specialized treatments. These factors have boosted the demand for medical imaging devices
Based on region, North America held the largest revenue share of about 48.35% in 2022. The growth is attributed to the growing adoption of minimally invasive surgeries and increasing demand for novel technologies
Grand View Research has segmented the global 3D medical imaging devices market based on device type, application, end-use, and region:
3D Medical Imaging Device Type Outlook (Revenue, USD Million, 2018 - 2030)
Hardware
X-ray Devices
CT Devices
Ultrasound Systems
MRI Equipment
Software
3D Medical Imaging Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Cardiology
Orthopedic
Gynecology
Others
3D Medical Imaging Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Imaging Centers
Others
3D Medical Imaging Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Norway
Sweden
Rest of Europe
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Rest of MEA
List of Key Players in the 3D Medical Imaging Devices Market
Siemens Healthineers
Esaote SpA
Koninklijke Philips N.V.
GE Healthcare Ltd.
Canon Medical Systems
Hitachi Medical Systems
Shimadzu Corporation
DigiRad Corporation
Del Medical Systems Inc.
"The quality of research they have done for us has been excellent..."